{"component": "definition", "props": {"groups": [{"samples": [{"hash": "fyU9yu51jLI", "uri": "/contracts/fyU9yu51jLI#cmc-development", "label": "Fourth Amendment and Restatement Agreement (CureVac N.V.)", "score": 33.3203277588, "published": true}, {"hash": "fyRsltWnB86", "uri": "/contracts/fyRsltWnB86#cmc-development", "label": "2020 Cla Amendment and Restatement Agreement (CureVac N.V.)", "score": 32.3182754517, "published": true}, {"hash": "gaeiYV2nMNw", "uri": "/contracts/gaeiYV2nMNw#cmc-development", "label": "Collaboration and License Agreement (CureVac B.V.)", "score": 31.5790557861, "published": true}], "snippet": "means all research and development activities conducted in respect of the Manufacture of Products, including chemistry, manufacturing and control (CMC), creation of master and working cell banks, test method development and stability testing, process development, manufacturing scale-up, qualification and validation, quality assurance and quality control processes and techniques.", "snippet_links": [{"key": "research-and-development-activities", "type": "clause", "offset": [10, 45]}, {"key": "in-respect-of", "type": "definition", "offset": [56, 69]}, {"key": "manufacture-of-products", "type": "clause", "offset": [74, 97]}, {"key": "working-cell-banks", "type": "definition", "offset": [176, 194]}, {"key": "method-development", "type": "clause", "offset": [201, 219]}, {"key": "stability-testing", "type": "clause", "offset": [224, 241]}, {"key": "process-development", "type": "definition", "offset": [243, 262]}, {"key": "qualification-and-validation", "type": "clause", "offset": [288, 316]}, {"key": "quality-control-processes", "type": "clause", "offset": [340, 365]}], "size": 16, "hash": "dfc39f00651c873a247d92db19b18d9b", "id": 1}, {"samples": [{"hash": "ddv9aqjUJhY", "uri": "/contracts/ddv9aqjUJhY#cmc-development", "label": "License and Technology Transfer Agreement (Cidara Therapeutics, Inc.)", "score": 35.6146469116, "published": true}, {"hash": "aOxKSKjDbik", "uri": "/contracts/aOxKSKjDbik#cmc-development", "label": "Exclusive License and Collaboration Agreement (Vaxart, Inc.)", "score": 34.8658447266, "published": true}, {"hash": "9SpRRGNX27W", "uri": "/contracts/9SpRRGNX27W#cmc-development", "label": "Research, License, and Collaboration Agreement (Dyadic International Inc)", "score": 32.9589309692, "published": true}], "snippet": "means Development activities related to the CMC of drug substance and drug product intended to ensure the proper identification, quality, purity and strength of the drug, including test method development and stability testing, process development, drug substance development, delivery system development, technology transfer, process validation, process scale-up, formulation development, quality assurance and quality control development.", "snippet_links": [{"key": "activities-related-to", "type": "clause", "offset": [18, 39]}, {"key": "drug-substance-and-drug-product", "type": "clause", "offset": [51, 82]}, {"key": "to-ensure", "type": "clause", "offset": [92, 101]}, {"key": "proper-identification", "type": "definition", "offset": [106, 127]}, {"key": "method-development", "type": "clause", "offset": [186, 204]}, {"key": "stability-testing", "type": "clause", "offset": [209, 226]}, {"key": "process-development", "type": "definition", "offset": [228, 247]}, {"key": "system-development", "type": "clause", "offset": [286, 304]}, {"key": "technology-transfer", "type": "definition", "offset": [306, 325]}, {"key": "process-validation", "type": "definition", "offset": [327, 345]}, {"key": "formulation-development", "type": "clause", "offset": [365, 388]}, {"key": "quality-assurance-and-quality-control", "type": "clause", "offset": [390, 427]}], "size": 13, "hash": "a53c08a3512a14b5518f48eb7f7d1f20", "id": 2}, {"samples": [{"hash": "hMy4YMgz02e", "uri": "/contracts/hMy4YMgz02e#cmc-development", "label": "License, Research, and Co Development Agreement (HCW Biologics Inc.)", "score": 37.1122518823, "published": true}, {"hash": "gxYb63lp5p4", "uri": "/contracts/gxYb63lp5p4#cmc-development", "label": "License, Research, and Co Development Agreement (HCW Biologics Inc.)", "score": 36.2361412048, "published": true}], "snippet": "means test method development and stability testing, process development, process validation, process scale-up, formulation development, delivery system development, quality assurance and quality control development, technology transfer and other related activities directed to establishing Manufacturing of a pharmaceutical product.", "snippet_links": [{"key": "method-development", "type": "clause", "offset": [11, 29]}, {"key": "stability-testing", "type": "clause", "offset": [34, 51]}, {"key": "process-development", "type": "definition", "offset": [53, 72]}, {"key": "process-validation", "type": "definition", "offset": [74, 92]}, {"key": "formulation-development", "type": "clause", "offset": [112, 135]}, {"key": "system-development", "type": "clause", "offset": [146, 164]}, {"key": "quality-assurance-and-quality-control", "type": "clause", "offset": [166, 203]}, {"key": "technology-transfer", "type": "definition", "offset": [217, 236]}, {"key": "other-related-activities", "type": "definition", "offset": [241, 265]}, {"key": "directed-to", "type": "definition", "offset": [266, 277]}, {"key": "pharmaceutical-product", "type": "definition", "offset": [310, 332]}], "size": 8, "hash": "3d426310eb9c313595183934104f945e", "id": 3}, {"samples": [{"hash": "6ckIv9GCUYs", "uri": "/contracts/6ckIv9GCUYs#cmc-development", "label": "License and Commercialization Agreement (Harmony Biosciences Holdings, Inc.)", "score": 33.8323059082, "published": true}, {"hash": "a6LBUztTs1H", "uri": "http://pdf.secdatabase.com/1729/0001558370-22-015726.pdf", "label": "pdf.secdatabase.com", "score": 9.5681037903, "published": false}, {"hash": "5h0RCkZKi7v", "uri": "https://ir.harmonybiosciences.com/static-files/2e0c0117-a962-4688-a1ab-c85e30d9df65", "label": "ir.harmonybiosciences.com", "score": 9.4599590302, "published": false}], "snippet": "means the CMC-related Development activities related to the composition, manufacture, and specification of a Product intended to assure the proper identification, quality, purity and strength thereof, including: site transfer, test method development and stability testing, process development, process improvements (improving product robustness or manufacturing efficiencies), drug substance development, process validation, process scale-up, formulation development, delivery system development, QA and QC development.", "snippet_links": [{"key": "activities-related-to", "type": "clause", "offset": [34, 55]}, {"key": "proper-identification", "type": "definition", "offset": [140, 161]}, {"key": "site-transfer", "type": "definition", "offset": [212, 225]}, {"key": "method-development", "type": "clause", "offset": [232, 250]}, {"key": "stability-testing", "type": "clause", "offset": [255, 272]}, {"key": "process-development", "type": "definition", "offset": [274, 293]}, {"key": "process-improvements", "type": "definition", "offset": [295, 315]}, {"key": "drug-substance", "type": "definition", "offset": [378, 392]}, {"key": "process-validation", "type": "definition", "offset": [406, 424]}, {"key": "formulation-development", "type": "clause", "offset": [444, 467]}, {"key": "system-development", "type": "clause", "offset": [478, 496]}], "size": 5, "hash": "939021662be950685989cdc4344705b9", "id": 4}, {"samples": [{"hash": "3wo73RJbPnH", "uri": "/contracts/3wo73RJbPnH#cmc-development", "label": "Collaboration Agreement (Galapagos Nv)", "score": 27.4147834778, "published": true}, {"hash": "ba5dwzZmfJF", "uri": "/contracts/ba5dwzZmfJF#cmc-development", "label": "Collaboration Agreement (Galapagos Nv)", "score": 26.338809967, "published": true}, {"hash": "3upD04oFsN", "uri": "/contracts/3upD04oFsN#cmc-development", "label": "Collaboration Agreement (Galapagos Nv)", "score": 26.2840518951, "published": true}], "snippet": "means chemistry, Manufacturing and controls development activities with respect to the Molecules and Products, including active pharmaceutical ingredient and formulation development, test method development, Manufacture/testing of active pharmaceutical ingredient and formulations (including placebos) for use in Clinical Studies, quality assurance, quality control development, development of the Manufacturing Process for the Products, scale-up, Manufacturing Process validation, including validation batches, Manufacturing Improvements, and qualification and validation of Third Party contract manufacturers.", "snippet_links": [{"key": "development-activities", "type": "definition", "offset": [44, 66]}, {"key": "with-respect-to", "type": "clause", "offset": [67, 82]}, {"key": "active-pharmaceutical-ingredient", "type": "definition", "offset": [121, 153]}, {"key": "formulation-development", "type": "clause", "offset": [158, 181]}, {"key": "method-development", "type": "clause", "offset": [188, 206]}, {"key": "clinical-studies", "type": "definition", "offset": [313, 329]}, {"key": "quality-assurance", "type": "clause", "offset": [331, 348]}, {"key": "quality-control", "type": "definition", "offset": [350, 365]}, {"key": "development-of-the", "type": "clause", "offset": [379, 397]}, {"key": "the-products", "type": "clause", "offset": [424, 436]}, {"key": "manufacturing-process-validation", "type": "clause", "offset": [448, 480]}, {"key": "validation-batches", "type": "clause", "offset": [492, 510]}, {"key": "manufacturing-improvements", "type": "definition", "offset": [512, 538]}, {"key": "qualification-and-validation", "type": "clause", "offset": [544, 572]}, {"key": "contract-manufacturers", "type": "clause", "offset": [588, 610]}], "size": 4, "hash": "58e9102aa867f1e6bea5edc25bba407a", "id": 5}, {"samples": [{"hash": "9qKzUF4b8SP", "uri": "/contracts/9qKzUF4b8SP#cmc-development", "label": "License Agreement (Edison Oncology Holding Corp)", "score": 36.9561958313, "published": true}, {"hash": "6nDvz5Ttkoa", "uri": "/contracts/6nDvz5Ttkoa#cmc-development", "label": "License Agreement (Edison Oncology Holding Corp)", "score": 36.1211509705, "published": true}, {"hash": "4JAceumFCZY", "uri": "/contracts/4JAceumFCZY#cmc-development", "label": "License Agreement (Edison Oncology Holding Corp)", "score": 34.4921302795, "published": true}], "snippet": "means the Development activities related to the composition, manufacture, and specification of the drug substance or biologic molecule and the drug product or biologic molecule (including combination products) intended to assure the proper identification, quality, purity and strength of the drug, including site transfer (as conducted pursuant to and in accordance with this Agreement), test method development and stability testing, process development, process improvements (i.e., improving product robustness or manufacturing efficiencies), drug substance or biologic molecule development, process validation, process scale- up, formulation development, delivery system development, quality assurance and quality control activities.", "snippet_links": [{"key": "activities-related-to", "type": "clause", "offset": [22, 43]}, {"key": "drug-substance", "type": "definition", "offset": [99, 113]}, {"key": "drug-product", "type": "definition", "offset": [143, 155]}, {"key": "combination-products", "type": "clause", "offset": [188, 208]}, {"key": "proper-identification", "type": "definition", "offset": [233, 254]}, {"key": "site-transfer", "type": "definition", "offset": [308, 321]}, {"key": "in-accordance-with", "type": "clause", "offset": [352, 370]}, {"key": "this-agreement", "type": "clause", "offset": [371, 385]}, {"key": "method-development", "type": "clause", "offset": [393, 411]}, {"key": "stability-testing", "type": "clause", "offset": [416, 433]}, {"key": "process-development", "type": "definition", "offset": [435, 454]}, {"key": "process-improvements", "type": "definition", "offset": [456, 476]}, {"key": "process-validation", "type": "definition", "offset": [594, 612]}, {"key": "formulation-development", "type": "clause", "offset": [633, 656]}, {"key": "system-development", "type": "clause", "offset": [667, 685]}, {"key": "quality-control-activities", "type": "definition", "offset": [709, 735]}], "size": 4, "hash": "bbcc159470f8695b4760069fdf18e74d", "id": 6}, {"samples": [{"hash": "j02KvuFtwed", "uri": "/contracts/j02KvuFtwed#cmc-development", "label": "Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.)", "score": 33.3203277588, "published": true}, {"hash": "kRA06mZnXJM", "uri": "/contracts/kRA06mZnXJM#cmc-development", "label": "Covid Collaboration and License Agreement", "score": 32.6830863953, "published": true}, {"hash": "6P8uO394Fqf", "uri": "/contracts/6P8uO394Fqf#cmc-development", "label": "Covid Collaboration and License Agreement (CureVac N.V.)", "score": 32.3182754517, "published": true}], "snippet": "means all research and development activities conducted in respect of the Manufacture of COVID Products, including chemistry, manufacturing and control (CMC), creation of master and working cell banks, test method development and stability testing, process development, manufacturing scale-up, qualification and validation, quality assurance and quality control processes and techniques.", "snippet_links": [{"key": "research-and-development-activities", "type": "clause", "offset": [10, 45]}, {"key": "in-respect-of", "type": "definition", "offset": [56, 69]}, {"key": "working-cell-banks", "type": "definition", "offset": [182, 200]}, {"key": "method-development", "type": "clause", "offset": [207, 225]}, {"key": "stability-testing", "type": "clause", "offset": [230, 247]}, {"key": "process-development", "type": "definition", "offset": [249, 268]}, {"key": "qualification-and-validation", "type": "clause", "offset": [294, 322]}, {"key": "quality-control-processes", "type": "clause", "offset": [346, 371]}], "size": 4, "hash": "811308331dfbe0c8af34f5526d35c23c", "id": 7}, {"samples": [{"hash": "jxK5TPey6qJ", "uri": "/contracts/jxK5TPey6qJ#cmc-development", "label": "License Agreement (Connetics Corp)", "score": 18.0, "published": true}, {"hash": "aL1mq3rEKmP", "uri": "/contracts/aL1mq3rEKmP#cmc-development", "label": "Development, Commercialization and License Agreement (Connetics Corp)", "score": 18.0, "published": true}], "snippet": "means all development activities relating to Product manufacturing, scale-up, quality assurance, quality control, Product characterization, and stability.", "snippet_links": [{"key": "development-activities", "type": "definition", "offset": [10, 32]}, {"key": "relating-to", "type": "definition", "offset": [33, 44]}, {"key": "product-manufacturing", "type": "definition", "offset": [45, 66]}, {"key": "quality-assurance", "type": "clause", "offset": [78, 95]}, {"key": "quality-control", "type": "definition", "offset": [97, 112]}], "size": 4, "hash": "692c9418074c12cf3766dfbb9770b5db", "id": 8}, {"samples": [{"hash": "3rTIwWFQzpL", "uri": "/contracts/3rTIwWFQzpL#cmc-development", "label": "License Agreement (Principia Biopharma Inc.)", "score": 29.6926765442, "published": true}, {"hash": "7huPQrXD4bK", "uri": "/contracts/7huPQrXD4bK#cmc-development", "label": "License Agreement (Principia Biopharma Inc.)", "score": 29.6187534332, "published": true}, {"hash": "a3ySVp3TBBW", "uri": "https://ir.principiabio.com/static-files/12c7993b-d723-4853-a856-c0805c26dda0", "label": "Amendment", "score": 14.1704311371, "published": false}], "snippet": "means all activities relating to the manufacturing of the Compound and Product for the supply of clinical and commercial quantities of Product, including test method development and stability testing, formulation, process development, manufacturing [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.", "snippet_links": [{"key": "relating-to", "type": "definition", "offset": [21, 32]}, {"key": "commercial-quantities", "type": "definition", "offset": [110, 131]}, {"key": "method-development", "type": "clause", "offset": [159, 177]}, {"key": "stability-testing", "type": "clause", "offset": [182, 199]}, {"key": "process-development", "type": "definition", "offset": [214, 233]}, {"key": "certain-confidential-information", "type": "clause", "offset": [255, 287]}, {"key": "contained-in", "type": "definition", "offset": [288, 300]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [350, 388]}, {"key": "pursuant-to-rule", "type": "clause", "offset": [389, 405]}, {"key": "securities-act-of-1933", "type": "clause", "offset": [417, 439]}, {"key": "as-amended", "type": "definition", "offset": [441, 451]}], "size": 3, "hash": "b03d97824305462254ed27906c81ab01", "id": 9}, {"samples": [{"hash": "i0VpO6XtJpM", "uri": "/contracts/i0VpO6XtJpM#cmc-development", "label": "License and Collaboration Agreement (Theravance Biopharma, Inc.)", "score": 32.1540031433, "published": true}, {"hash": "BioDKnRLkL", "uri": "/contracts/BioDKnRLkL#cmc-development", "label": "License and Collaboration Agreement (Theravance Biopharma, Inc.)", "score": 29.3504447937, "published": true}, {"hash": "4rXx1PSV5Ic", "uri": "https://investor.theravance.com/static-files/658e2290-0a40-414c-9285-ee2b94eeec07", "label": "investor.theravance.com", "score": 9.1724843979, "published": false}], "snippet": "means (a) Development activities related to the composition, manufacture and specification of Compound API and Product intended to assure the proper identification, quality, purity and strength of the Product, including: test method development and stability testing, process development, Compound API process development, process validation, process scale-up, formulation development, packaging development, quality assurance and quality control development; and (b) preparation of CMC Regulatory Materials.", "snippet_links": [{"key": "activities-related-to", "type": "clause", "offset": [22, 43]}, {"key": "api-and-product", "type": "clause", "offset": [103, 118]}, {"key": "proper-identification", "type": "definition", "offset": [142, 163]}, {"key": "the-product", "type": "definition", "offset": [197, 208]}, {"key": "method-development", "type": "clause", "offset": [226, 244]}, {"key": "stability-testing", "type": "clause", "offset": [249, 266]}, {"key": "process-development", "type": "definition", "offset": [268, 287]}, {"key": "process-validation", "type": "definition", "offset": [323, 341]}, {"key": "formulation-development", "type": "clause", "offset": [361, 384]}, {"key": "quality-assurance-and-quality-control", "type": "clause", "offset": [409, 446]}, {"key": "preparation-of", "type": "clause", "offset": [468, 482]}, {"key": "regulatory-materials", "type": "definition", "offset": [487, 507]}], "size": 3, "hash": "1c20b0899dc3b3838ebb252c7a9c0e2b", "id": 10}], "next_curs": "ClwSVmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjgLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIYY21jLWRldmVsb3BtZW50IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means all research and development activities conducted in respect of the Manufacture of Products, including chemistry, manufacturing and control (CMC), creation of master and working cell banks, test method development and stability testing, process development, manufacturing scale-up, qualification and validation, quality assurance and quality control processes and techniques.", "title": "CMC Development", "size": 90, "id": "cmc-development", "examples": ["For clarity, Dynavax shall be responsible for conducting or having conducted all <strong>CMC Development</strong> for the Vaccine Candidate and related Product after the Effective Date, at Dynavax\u2019s sole cost and expense, but excluding <strong>CMC Development</strong> of the Vaxart Platform generally or the Vaxart Platform for use or incorporation in compounds that are not Compounds or products that are not Products, for which Vaxart shall be solely responsible at Vaxart\u2019s sole cost and expense."], "related": [["economic-development", "Economic development", "Economic development"], ["infill-development", "Infill development", "Infill development"], ["clinical-development", "Clinical Development", "Clinical Development"], ["experimental-development", "experimental development", "experimental development"], ["commercial-development", "Commercial Development", "Commercial Development"]], "related_snippets": [], "updated": "2026-02-13T05:59:08+00:00"}, "json": true, "cursor": ""}}